India Uterine Cancer Market Size & Outlook, 2025-2033


India Uterine Cancer Market Insights

  • As per Reed Intelligence insights, the India Uterine Cancer Market stood at USD 193.88 Million in 2024 and is anticipated to grow to USD 300.45 Million by 2033.
  • The India market is expected to advance at a CAGR of 4.97% from 2026 through 2033.
  • In 2024, Endometrial Adenocarcinoma accounted for the highest share of the By Type market size.
  • During the forecast period, Endometrial Adenocarcinoma is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • In 2024, India represented 3.1% of the overall global Uterine Cancer Market size.
  • United States is projected to lead the global Uterine Cancer Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • South Korea is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 82.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 193.88 Million
Market Size In 2033 USD 300.45 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 4.97% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends